K.C. was initially diagnosed with stage 3 lung cancer in 2015. After receiving chemotherapy and radiation, her healthcare team was not optimistic—her cancer had spread to her lymph nodes and progressed to stage 4. K.C. sought a second opinion in Houston and began treatment of nivolumab. #CIM18 #PatientStories
She responded to the immunotherapy immediately, and her recent scans show no evidence of disease. Today K.C. continues to work full-time and experiences new adventures with her two daughters, Avery and Anna, and her husband, Joey.
This video is presented as part of the Cancer Research Institute 6th Annual Cancer Immunotherapy Month awareness campaign this June 2018. Learn more about cancer immunotherapy and its potential to save more lives at
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers.
lung cancer, stage 3, stage 4, baylor, patient stories, baylor college of medicine, cancer research institute, cancer immunotherapy month, cancer immunotherapy, nivolumab, immunotherapy, cancer treatment, cancer research, clinical trial, immunotherapy stories, stage 4 lung cancer, stage 4 lung cancer survivor
See other Health articles